Showing results (81-90 of 172) with videos related to

Sort By:
Pageof 18
Cardiovascular Endocrinology & Metabolism|June 15, 2022
Can glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors help in mitigating the risk of atrial fibrillation in patients with diabetes?Sahith Reddy Thotamgari, Udhayvir Singh Grewal, Aakash R Sheth, et al.
Cardiovascular Endocrinology & Metabolism|October 25, 2019
Heart failure: an underestimated therapeutic target in diabetesNikolaus Marx
Cardiovascular Endocrinology & Metabolism|October 25, 2019
Integrating cardioprotective glucose-lowering medications into clinical practiceSunder Mudaliar
Cardiovascular Endocrinology & Metabolism|October 25, 2019
The role of OPG/RANKL in the pathogenesis of diabetic cardiovascular diseaseHannah Forde, Colin Davenport, Emma Harper, et al.
Cardiovascular Endocrinology & Metabolism|October 25, 2019
Diagnostic challenges in supraventricular tachycardia: anticipating value of natriuretic peptidesErtan Yetkin
Cardiovascular Endocrinology & Metabolism|October 25, 2019
Association between thyroid abnormalities and hypertension among hospitalized US patients: data from the National Inpatient SampleSijan Basnet, Rashmi Dhital, Biswaraj Tharu, et al.
Cardiovascular Endocrinology & Metabolism|October 25, 2019
Vascular disease in the lower limb in type 1 diabetesMichael Edmonds
Cardiovascular Endocrinology & Metabolism|October 25, 2019
Association of neutrophil-gelatinase-associated lipocalin with microvascular complications in patients with type 2 diabetes: a cross-sectional studyErhan Aslanhan, David Ojalvo, Ekmek Burak Özsenel, et al.
Pageof 18